AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11205494 — intervention group
Group type: EXPERIMENTAL
Intervention: KRAS mutation in 72-month biopsies
Number of subjects: 863
Study 9466971 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (100 mg daily)
Number of subjects: 9
Study 9466971 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 8955577 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine release (HR) with commercial extract
Number of subjects: 38
Study 8955577 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific IgE analyses (three commercially available tests)
Number of subjects: 38
Study 8955577 — intervention group
Group type: EXPERIMENTAL
Intervention: Freshly prepared codfish extracts with HR
Number of subjects: 38
Study 8955577 — intervention group
Group type: EXPERIMENTAL
Intervention: Phadebas RAST, CAP, and in-house RAST
Number of subjects: 38
Study 8955577 — intervention group
Group type: EXPERIMENTAL
Intervention: Magic Lite (ML)
Number of subjects: 38
Study 2082886 — intervention group
Group type: EXPERIMENTAL
Intervention: Cord drainage of placental blood
Number of subjects: 1908
Study 2082886 — intervention group
Group type: COMPARATOR
Intervention: Control group (cord clamped)
Number of subjects: 1908
Study 395826 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlordiazepoxide
Number of subjects: 663
Study 395826 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 663
Study 395826 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 663
Study 31352473 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment
Number of subjects: 0
Study 31352473 — intervention group
Group type: COMPARATOR
Intervention: Intensive nodal observation
Number of subjects: 0
Study 27943008 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 469
Study 27943008 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 469
Study 25786517 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral isthmus (MI) ablation from the left inferior PV to the posterior mitral annulus (group 1)
Number of subjects: 40
Study 25786517 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral isthmus (MI) ablation from the left inferior PV to the anterolateral mitral annulus (group 2)
Number of subjects: 40
Study 25786517 — intervention group
Group type: EXPERIMENTAL
Intervention: Incomplete MI block
Number of subjects: 40
Study 25786517 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of the MI
Number of subjects: 40
Study 25336068 — intervention group
Group type: EXPERIMENTAL
Intervention: Hatha yoga intervention (12-week, twice-weekly)
Number of subjects: 200
Study 25336068 — intervention group
Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 200
Study 24168465 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-based case management (n=161) including home visits and telephone calls for one year.
Number of subjects: 340
Study 24168465 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=168).
Number of subjects: 340
Study 21167355 — intervention group
Group type: COMPARATOR
Intervention: No ICD
Number of subjects: 6378
Study 18307484 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous pushing technique (open glottis pushing while breathing out)
Number of subjects: 100
Study 18307484 — intervention group
Group type: COMPARATOR
Intervention: Valsalva-type pushing technique (closed glottis pushing while holding their breath)
Number of subjects: 100
Study 16542201 — intervention group
Group type: EXPERIMENTAL
Intervention: Tezosentan (2.5, 5.0, 12.5 and 25 mg h(‐1))
Number of subjects: 24
Study 16542201 — intervention group
Group type: EXPERIMENTAL
Intervention: Tezosentan
Number of subjects: 24
Study 12703845 — intervention group
Group type: EXPERIMENTAL
Intervention: First series of tests (five 10 min sub‐maximal cycle exercise bouts, VO2peak test, 115% VO2peak test)
Number of subjects: 10
Study 12703845 — intervention group
Group type: COMPARATOR
Intervention: Second series of tests (15 min incremental cycle ergometer test followed by a 2 min variable resistance test)
Number of subjects: 10
Study 12703845 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified protocol (second series)
Number of subjects: 10
Study 12703845 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified 2 min maximal test
Number of subjects: 10
Study 11121631 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifostine
Number of subjects: 35
Study 11121631 — intervention group
Group type: COMPARATOR
Intervention: Control (no amifostine)
Number of subjects: 35
Study 9489813 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) treatment for RA
Number of subjects: 26
Study 7836695 — intervention group
Group type: COMPARATOR
Intervention: D-propoxyphene (0.7 mg/kg body weight)
Number of subjects: 29
Study 3402341 — intervention group
Group type: EXPERIMENTAL
Intervention: Cavafix catheter
Number of subjects: 3000
Study 3402341 — intervention group
Group type: EXPERIMENTAL
Intervention: Early catheter removal
Number of subjects: 3000
Study 3402341 — intervention group
Group type: COMPARATOR
Intervention: Routine weekly catheter replacement
Number of subjects: 3000
Study 3402341 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing and supervision by trained personnel
Number of subjects: 3000
Study 29659956 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape juice polyphenols (GJPs) 300 mg/d for 1 month
Number of subjects: 40
Study 29659956 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 1 month
Number of subjects: 40
Study 28626018 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippocampal oscillations under conflict
Number of subjects: 23
Study 28626018 — intervention group
Group type: EXPERIMENTAL
Intervention: Theta oscillations
Number of subjects: 23
Study 28626018 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma power modulation
Number of subjects: 23
Study 26053138 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg of galactose/day followed by 500 mg for 2 weeks
Number of subjects: 26
Study 26053138 — intervention group
Group type: COMPARATOR
Intervention: Control group (13 patients)
Number of subjects: 26
Study 23641006 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT) ON
Number of subjects: 419
Study 21139035 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional acupuncture
Number of subjects: 36
Study 21139035 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 36
Study 21139035 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 36
Study 19051551 — intervention group
Group type: EXPERIMENTAL
Intervention: Rembrandt Plus‐‐peroxide whitening rinse
Number of subjects: 30
Study 19051551 — intervention group
Group type: EXPERIMENTAL
Intervention: Listerine‐‐alcohol containing
Number of subjects: 30
Study 19051551 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral B‐‐alcohol free
Number of subjects: 30
Study 19051551 — intervention group
Group type: COMPARATOR
Intervention: 10% carbamide peroxide bleaching agent (Vivastyle)
Number of subjects: 30
Study 16815189 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled morphine (65 mug kg(‐1) morphine sulphate, 3 mL via oral nebulizer)
Number of subjects: 80
Study 16815189 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride (physiological saline, 3 mL via oral nebulizer)
Number of subjects: 80
Study 16815189 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled morphine
Number of subjects: 80
Study 16815189 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride
Number of subjects: 80
Study 15124547 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (20-25 Gy) in stage I seminoma
Number of subjects: 0
Study 15124547 — intervention group
Group type: COMPARATOR
Intervention: Surveillance instead of postoperative radiotherapy in stage I seminoma
Number of subjects: 0
Study 15124547 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy limited to the paraortic area in stage IIa seminoma
Number of subjects: 0
Study 15124547 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy in stage IIb and higher seminoma
Number of subjects: 0
Study 15124547 — intervention group
Group type: EXPERIMENTAL
Intervention: Association of carboplatin and radiotherapy
Number of subjects: 0
Study 15124547 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel radiotherapeutic approaches
Number of subjects: 0
Study 15124547 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryptorchid seminoma and HCG-producing seminoma
Number of subjects: 0
Study 10882586 — intervention group
Group type: EXPERIMENTAL
Intervention: Protease inhibitor-containing regimen
Number of subjects: 147
Study 10882586 — intervention group
Group type: COMPARATOR
Intervention: Dual nucleoside analogue regimen
Number of subjects: 147
Study 8672377 — intervention group
Group type: EXPERIMENTAL
Intervention: Subanaesthetic isoflurane 0.16 vol%
Number of subjects: 10
Study 8672377 — intervention group
Group type: EXPERIMENTAL
Intervention: Subanaesthetic isoflurane 0.24 vol%
Number of subjects: 10
Study 8672377 — intervention group
Group type: EXPERIMENTAL
Intervention: Subanaesthetic isoflurane 0.08 vol%
Number of subjects: 10
Study 8672377 — intervention group
Group type: EXPERIMENTAL
Intervention: All concentrations of isoflurane (0.08, 0.16, 0.24 vol%)
Number of subjects: 10
Study 7565327 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacine
Number of subjects: 0
Study 7565327 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic therapies, ampicillin, co‐trimoxazole
Number of subjects: 0
Study 3344730 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate
Number of subjects: 64
Study 3344730 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 64
Study 31056570 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional Triamcinolone Acetonide (TA)
Number of subjects: 118
Study 31056570 — intervention group
Group type: COMPARATOR
Intervention: Incision and Curettage (I&C)
Number of subjects: 118
Study 28596103 — intervention group
Group type: EXPERIMENTAL
Intervention: Training intervention for GPs (9 hours of interactive training on youth-friendly care, psychosocial health risk screening, and motivational interviewing)
Number of subjects: 40
Study 28596103 — intervention group
Group type: EXPERIMENTAL
Intervention: Training intervention for GPs
Number of subjects: 40
Study 28596103 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training intervention)
Number of subjects: 40
Study 26222093 — intervention group
Group type: EXPERIMENTAL
Intervention: M Technique (structured touch)
Number of subjects: 225
Study 26222093 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 225
Study 26222093 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 225
Study 23724526 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (OND)
Number of subjects: 83
Study 23724526 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide (MET)
Number of subjects: 83
Study 20492840 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg/d)
Number of subjects: 115
Study 20492840 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study 20492840 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 115
Study 19016988 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodynamic Assessment
Number of subjects: 200
Study 19016988 — intervention group
Group type: COMPARATOR
Intervention: Manual Assessment
Number of subjects: 200
Study 17012455 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral medroxyprogesterone acetate 20 mg, administered three times per day for 1 week, then 20 mg per day for the next 3 weeks
Number of subjects: 40
Study 17012455 — intervention group
Group type: COMPARATOR
Intervention: Monophasic combination oral contraceptive (OC) containing 1 mg norethindrone and 35 mcg of ethinyl estradiol, administered three times per day for 1 week, then one tablet per day for the next 3 weeks
Number of subjects: 40
Study 15040791 — intervention group
Group type: COMPARATOR
Intervention: Patient information booklet about menorrhagia and treatment options, mailed before the first visit to the outpatient clinic.
Number of subjects: 363
Study 10740328 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral trimegestone (0.05, 0.1, 0.25 and 0.5 mg per day)
Number of subjects: 176
Study 9415221 — intervention group
Group type: EXPERIMENTAL
Intervention: Amorphous injectable form of aztreonam (BIOKTAM)
Number of subjects: 0
Study 9415221 — intervention group
Group type: COMPARATOR
Intervention: AZACTAM
Number of subjects: 0
Study 1280464 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional radiotherapy after chemotherapy
Number of subjects: 0
Study 1280464 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional radiotherapy for nodular sclerosis histology subgroup
Number of subjects: 0
Study 1280464 — intervention group
Group type: COMPARATOR
Intervention: No further treatment or additional chemotherapy
Number of subjects: 0
Study 6424827 — intervention group
Group type: EXPERIMENTAL
Intervention: Early (aggressive) surgical management
Number of subjects: 142
Study 6424827 — intervention group
Group type: COMPARATOR
Intervention: Delayed (conservative) policy
Number of subjects: 142
Study 6424827 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgical management for gastric ulcer
Number of subjects: 142
Study 6424827 — intervention group
Group type: COMPARATOR
Intervention: Delayed surgical management for gastric ulcer
Number of subjects: 142
Study 30865315 — intervention group
Group type: EXPERIMENTAL
Intervention: 75-mg single-dose solriamfetol in normal renal function
Number of subjects: 37
Study 30865315 — intervention group
Group type: EXPERIMENTAL
Intervention: 75-mg single-dose solriamfetol in mild renal impairment
Number of subjects: 37
Study 30865315 — intervention group
Group type: EXPERIMENTAL
Intervention: 75-mg single-dose solriamfetol in moderate renal impairment
Number of subjects: 37
Study 30865315 — intervention group
Group type: EXPERIMENTAL
Intervention: 75-mg single-dose solriamfetol in severe renal impairment
Number of subjects: 37
Study 30865315 — intervention group
Group type: EXPERIMENTAL
Intervention: 75-mg single-dose solriamfetol in ESRD without hemodialysis
Number of subjects: 37
Study 30865315 — intervention group
Group type: EXPERIMENTAL
Intervention: 75-mg single-dose solriamfetol in ESRD with hemodialysis
Number of subjects: 37
Study 30865315 — intervention group
Group type: EXPERIMENTAL
Intervention: 75-mg single-dose solriamfetol in ESRD with and without hemodialysis
Number of subjects: 37
Study 30865315 — intervention group
Group type: EXPERIMENTAL
Intervention: 75-mg single-dose solriamfetol during hemodialysis
Number of subjects: 37
Study 30865315 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events related to solriamfetol
Number of subjects: 37
Study 30865315 — intervention group
Group type: EXPERIMENTAL
Intervention: Study drug-related adverse events
Number of subjects: 37
Study 30583748 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating bio‐ADM levels upon admission > 70 pg/ml
Number of subjects: 583
Study 30583748 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistently elevated bio‐ADM at day 2
Number of subjects: 583
Study 26992115 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioabsorbable steroid-eluting sinus implant (mometasone furoate)
Number of subjects: 100
Study 26992115 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 100
Study 25262257 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-antiplatelet therapy (DAPT)
Number of subjects: 3691
Study 25262257 — intervention group
Group type: COMPARATOR
Intervention: Single-antiplatelet therapy (SAPT)
Number of subjects: 3691
Study 25262257 — intervention group
Group type: EXPERIMENTAL
Intervention: DAPT
Number of subjects: 3691
Study 25262257 — intervention group
Group type: COMPARATOR
Intervention: SAPT
Number of subjects: 3691
Study 22301127 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated Diabetes Management System (ADMS)
Number of subjects: 48
Study 22301127 — intervention group
Group type: COMPARATOR
Intervention: Conventional care without technology (Control)
Number of subjects: 48
Study 19626571 — intervention group
Group type: EXPERIMENTAL
Intervention: Early repair of episiotomy before expulsion of placenta (Group 1)
Number of subjects: 120
Study 19626571 — intervention group
Group type: COMPARATOR
Intervention: Repair of episiotomy after spontaneous placental expulsion (Group 2)
Number of subjects: 120
Study 19626571 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study 17436202 — intervention group
Group type: EXPERIMENTAL
Intervention: Echinacea supplement for 4 weeks
Number of subjects: 32
Study 17436202 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 32
Study 16214443 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin treatment for 6 months
Number of subjects: 75
Study 12001761 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate or carbamazepine in monotherapy or combination of phenobarbital and phenytoin and the combination of phenobarbital, phenytoin and primidone in polytherapy
Number of subjects: 53
Study 12001761 — intervention group
Group type: EXPERIMENTAL
Intervention: Group E (women with epilepsy)
Number of subjects: 53
Study 10544903 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (UH) given as an intravenous bolus of 80 U/kg followed by a constant infusion of 18 U/kg/h
Number of subjects: 20
Study 10544903 — intervention group
Group type: COMPARATOR
Intervention: Nadroparin 185 AXa IU/kg once daily subcutaneously
Number of subjects: 20
Study 10544903 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary endpoints
Number of subjects: 20
Study 7792126 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil (8 mg/kg/day twice daily)
Number of subjects: 348
Study 7792126 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin-clavulanate (amoxicillin 40 mg/kg/day 3 times a day)
Number of subjects: 348
Study 1977256 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream applied for 30, 60, 90, and 120 min on various body locations.
Number of subjects: 0
Study 1977256 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream on the back.
Number of subjects: 0
Study 1977256 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream in the cubital fossa and on the hand.
Number of subjects: 0
Study 1977256 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of cutaneous blood flow.
Number of subjects: 0
Study 1977256 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidermal and dermal thickness measurements.
Number of subjects: 0
Study 6778189 — intervention group
Group type: EXPERIMENTAL
Intervention: tocainide
Number of subjects: 146
Study 6778189 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 146
Study 31505520 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety NOS diagnosis based on electronic medical record
Number of subjects: 61
Study 31505520 — intervention group
Group type: COMPARATOR
Intervention: Structured diagnostic interview
Number of subjects: 61
Study 27964962 — intervention group
Group type: EXPERIMENTAL
Intervention: PUSH (multi-component physiotherapy intervention based on aerobic conditioning, specificity of training, and muscle overload)
Number of subjects: 210
Study 27964962 — intervention group
Group type: COMPARATOR
Intervention: PULSE (non-specific multi-component control physiotherapy intervention including transcutaneous electrical nerve stimulation, flexibility activities, and active range of motion exercises)
Number of subjects: 210
Study 27964962 — intervention group
Group type: EXPERIMENTAL
Intervention: PUSH
Number of subjects: 210
Study 27964962 — intervention group
Group type: COMPARATOR
Intervention: PULSE
Number of subjects: 210
Study 25533243 — intervention group
Group type: EXPERIMENTAL
Intervention: 5Hz‐rTMS (treatment)
Number of subjects: 0
Study 25533243 — intervention group
Group type: COMPARATOR
Intervention: Sham (placebo) stimulation
Number of subjects: 0
Study 23647888 — intervention group
Group type: EXPERIMENTAL
Intervention: High-saturated fatty acid (HSFA) diet
Number of subjects: 0
Study 23647888 — intervention group
Group type: EXPERIMENTAL
Intervention: High-monounsaturated fatty acid (HMUFA) diet
Number of subjects: 0
Study 23647888 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat, high-complex carbohydrate diet supplemented with n-3 polyunsaturated fatty acids (LFHCC n3)
Number of subjects: 0
Study 23647888 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat, high-complex carbohydrate diet (LFHCC)
Number of subjects: 0
Study 20144522 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-physician communication skills training
Number of subjects: 28
Study 20144522 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 28
Study 19494551 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of tests for orientation, memory, attention, executive function, and abstraction and judgment
Number of subjects: 625
Study 19494551 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of tests for memory, attention, executive function, and abstraction and judgment (excluding orientation)
Number of subjects: 625
Study 19494551 — intervention group
Group type: COMPARATOR
Intervention: Mini Mental State Examination
Number of subjects: 625
Study 16423089 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg q.d., esomeprazole 20 mg b.i.d., and amoxicillin 1 g b.i.d.
Number of subjects: 85
Study 16423089 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole 40 mg b.i.d., tripotassium dicitrate bismuthate 300 mg q.i.d., metronidazole 500 mg t.i.d., and tetracycline 500 mg q.i.d.
Number of subjects: 85
Study 15598479 — intervention group
Group type: COMPARATOR
Intervention: Gefitinib 250 mg tablet
Number of subjects: 18
Study 15598479 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib dispersion preparation via drink
Number of subjects: 18
Study 15598479 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib dispersion preparation via nasogastric tube
Number of subjects: 18
Study 15598479 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events (AEs) related to gefitinib
Number of subjects: 18
Study 11306524 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE+MP (micronized progesterone 200 mg)
Number of subjects: 20
Study 11306524 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE+MPA (medroxyprogesterone acetate 10 mg)
Number of subjects: 20
Study 9403262 — intervention group
Group type: EXPERIMENTAL
Intervention: Betadine cold sore paint
Number of subjects: 72